company background image
688298 logo

Zhejiang Orient Gene BiotechLtd SHSE:688298 Stock Report

Last Price

CN¥30.06

Market Cap

CN¥6.1b

7D

-6.1%

1Y

-47.2%

Updated

28 Mar, 2024

Data

Company Financials

Zhejiang Orient Gene Biotech Co.,Ltd

SHSE:688298 Stock Report

Market Cap: CN¥6.1b

688298 Stock Overview

Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide.

688298 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends2/6

Zhejiang Orient Gene Biotech Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Orient Gene BiotechLtd
Historical stock prices
Current Share PriceCN¥30.06
52 Week HighCN¥57.62
52 Week LowCN¥25.00
Beta1.75
1 Month Change-8.27%
3 Month Change-15.94%
1 Year Change-47.16%
3 Year Change-60.36%
5 Year Changen/a
Change since IPO-65.41%

Recent News & Updates

Recent updates

Shareholder Returns

688298CN BiotechsCN Market
7D-6.1%-6.3%-4.9%
1Y-47.2%-21.2%-16.6%

Return vs Industry: 688298 underperformed the CN Biotechs industry which returned -21.2% over the past year.

Return vs Market: 688298 underperformed the CN Market which returned -16.6% over the past year.

Price Volatility

Is 688298's price volatile compared to industry and market?
688298 volatility
688298 Average Weekly Movement7.8%
Biotechs Industry Average Movement8.1%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688298 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688298's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20052,242Xiaoliang Fanghttps://www.orientgene.com

Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products.

Zhejiang Orient Gene Biotech Co.,Ltd Fundamentals Summary

How do Zhejiang Orient Gene BiotechLtd's earnings and revenue compare to its market cap?
688298 fundamental statistics
Market capCN¥6.06b
Earnings (TTM)-CN¥372.07m
Revenue (TTM)CN¥824.13m

7.4x

P/S Ratio

-16.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688298 income statement (TTM)
RevenueCN¥824.13m
Cost of RevenueCN¥0
Gross ProfitCN¥824.13m
Other ExpensesCN¥1.20b
Earnings-CN¥372.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 30, 2024

Earnings per share (EPS)-1.85
Gross Margin100.00%
Net Profit Margin-45.15%
Debt/Equity Ratio7.3%

How did 688298 perform over the long term?

See historical performance and comparison

Dividends

5.5%

Current Dividend Yield

-32%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.